Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
242.50    7.50 (3.19%)
Bid:
240.00
Ask:
245.00
Spread: 5.00 (2.083%)
Market Cap: £87.20m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Interim Management Statement

18 May 2009 07:00

RNS Number : 3735S
Alumasc Group PLC
18 May 2009
 



Monday 18 May 2009  

THE ALUMASC GROUP PLC - INTERIM MANAGEMENT STATEMENT

Alumasc (ALU.L), the premium building and engineering products company, is publishing its second interim management statement relating to the year ending 30 June 2009.

 

The group's trading performance has shown some seasonal improvement during the Spring, following the very challenging conditions experienced by the Engineering Products division in particular during the Winter. The group's Building Products division has continued to deliver a robust performance, with year to date revenues across the sustainable building product businesses exceeding strong prior period comparators.

In the first ten months of the year, Building Products' divisional revenues (representing over 70% of group revenues) were similar to those in the prior period. Sustainable building product revenues were over 5% ahead, assisted by the acquisition of the Blackdown green roof business in March 2008, but still ahead on a like-for-like basis. Levolux, the UK's leading solar shading company, acquired two years ago, has continued to deliver an outstanding performance. Blackdown has performed strongly in recent months, reflecting continued growth in the market for green roofs. Demand for MR Façade systems, sold principally into the social housing refurbishment market, also remains buoyant. Year to date divisional operating margins are around 1 percentage point lower than in the prior period, largely reflecting the impact of currency appreciation on imported products, as described in our interim report. Whilst the group's Building Products businesses continue to perform relatively well, these activities are not immune to current economic and market conditions and there is increasing evidence from both external commentators and in our own order books that demand for new commercial buildings will continue to weaken in the short-term. 

Engineering Products' divisional revenues (which now represent less than 30% of group revenues) were over 20% below those in the first ten months of the prior year, reflecting the significant downturn in demand from OEM customers that began to impact Alumasc just prior to the calendar year end. Activity levels remain subdued in this division, with revenues since December down by some 40% compared with a year ago. Since our interim report, the new management team at Alumasc Precision has taken further action to drive operational efficiencies and re-align the cost base to reflect the lower levels of demand. 

The group's cash performance has remained strong, with working capital requirements reduced and capital expenditure controlled carefully. Net debt at 30 April of £13.1 million was higher than at the interim stage, largely due to seasonal factors (including the recent payment of the interim dividend and quarterly VAT) but is expected to reduce to around £10-11 million by the year end (30 June 2008: £9.4 million), implying gearing of just over 30%. There have been no other significant changes to the group's balance sheet since 31 December 2008. 

Although overall trading results have shown some recent seasonal improvement, in view of the continuing low level of demand in the Engineering Products division, the Board now expects that overall results for the current year will be marginally lower than its previous expectations. 

Nonetheless, the Board has confidence that the group is increasingly well positioned to benefit from opportunities arising from the recession and from economic recovery when it comes. The level of customer enquiries for potential new work at Alumasc Precision is higher than it has been for a number of years. Alumasc's overall cost base has been reduced by almost £6 million on an annualised basis this year, and management is working hard to develop some exciting opportunities for further export sales. 

Enquiries:

The Alumasc Group plc

Paul Hooper (Group Chief Executive)  Tel: 01536 383821

Andrew Magson (Group Finance Director) Tel: 01536 383844

Bankside Consultants

Charles Ponsonby/Rose Oddy  Tel: 0207 367 8851

This Interim Management Statement has been drawn up and presented for the purposes of complying with English law. Any liability arising out of or in connection with this Interim Management Statement will also be determined in accordance with English law.

This Interim Management Statement may contain 'forward-looking statements'. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Many of these risks and uncertainties relate to factors beyond The Alumasc Group's control or which cannot be estimated precisely, such as future market conditions and the behaviour of the market participants. Actual outcomes and results may therefore differ materially from any outcomes or results expressed or implied by any such forward-looking statements.

Nothing in this Interim Management Statement is intended to be a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEELFFKEBZBBX
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.